Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake
Abstract Background Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease predominantly affecting women. Despite the availability of FDA-approved treatments, mTOR inhibitors like sirolimus or everolimus, significant disparities persist in early diagnosis, treatment utilization, and pati...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-02-01
|
| Seri Bilgileri: | Orphanet Journal of Rare Diseases |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13023-026-04284-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|